Mathur Amit K, Ashby Valarie B, Fuller Douglas S, Zhang Min, Merion Robert M, Leichtman Alan, Kalbfleisch John
1 Department of Surgery, University of Michigan Ann Arbor, MI. 2 Department of Biostatistics, University of Michigan Ann Arbor, MI. 3 Kidney Epidemiology and Cost Center, University of Michigan Ann Arbor, MI. 4 Arbor Research Collaborative for Health, Ann Arbor, MI. 5 Department of Medicine, University of Michigan Ann Arbor, MI. 6 Address correspondence to: Amit K. Mathur, M.D., M.S., 2922 Taubman Center, SPC 5300, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5300.
Transplantation. 2014 Jul 15;98(1):94-9. doi: 10.1097/01.TP.0000443223.89831.85.
We sought to compare liver transplant waiting list access by demographics and geography relative to the pool of potential liver transplant candidates across the United States using a novel metric of access to care, termed a liver wait-listing ratio (LWR).
We calculated LWRs from national liver transplant registration data and liver mortality data from the Scientific Registry of Transplant Recipients and the National Center for Healthcare Statistics from 1999 to 2006 to identify variation by diagnosis, demographics, geography, and era.
Among patients with ALF and CLF, African Americans had significantly lower access to the waiting list compared with whites (acute: 0.201 versus 0.280; pre-MELD 0.201 versus 0.290; MELD era: 0.201 versus 0.274; all, P<0.0001) (chronic: 0.084 versus 0.163; pre-MELD 0.085 versus 0.179; MELD 0.084 versus 0.154; all, P<0.0001). Hispanics and whites had similar LWR in both eras (both P>0.05). In the MELD era, female subjects had greater access to the waiting list compared with male subjects (acute: 0.428 versus 0.154; chronic: 0.158 versus 0.140; all, P<0.0001). LWRs varied by three-fold by state (pre-MELD acute: 0.122-0.418, chronic: 0.092-0.247; MELD acute: 0.121-0.428, chronic: 0.092-0.243).
The marked inequity in early access to liver transplantation underscores the need for local and national policy initiatives to affect this disparity.
我们试图通过一种新的医疗可及性指标,即肝脏等待名单比率(LWR),来比较美国不同人口统计学特征和地理位置的人群相对于潜在肝脏移植候选者群体而言,在肝脏移植等待名单上的可及性。
我们根据1999年至2006年美国器官共享联合网络(UNOS)的全国肝脏移植登记数据以及来自移植受者科学登记处和国家卫生统计中心的肝脏死亡率数据计算LWR,以确定不同诊断、人口统计学特征、地理位置和时期的差异。
在急性肝功能衰竭(ALF)和慢性肝功能衰竭(CLF)患者中,非裔美国人进入等待名单的机会显著低于白人(急性:0.201对0.280;MELD之前:0.201对0.290;MELD时代:0.201对0.274;所有比较,P<0.0001)(慢性:0.084对0.163;MELD之前:0.085对0.179;MELD:0.084对0.154;所有比较,P<0.0001)。西班牙裔和白人在两个时期的LWR相似(均P>0.05)。在MELD时代,女性进入等待名单的机会高于男性(急性:0.428对0.154;慢性:0.158对0.140;所有比较,P<0.0001)。不同州的LWR相差三倍(MELD之前急性:0.122 - 0.418,慢性:0.092 - 0.247;MELD急性:0.121 - 0.428,慢性:0.092 - 0.243)。
早期肝脏移植可及性的显著不平等凸显了采取地方和国家政策举措来消除这种差距的必要性。